KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Preferred Shares Issued: 2019-2020

Historic Preferred Shares Issued for AbCellera Biologics (ABCL) over the last 2 years, with Dec 2020 value amounting to $74.7 million.

  • AbCellera Biologics' Preferred Shares Issued was N/A to -$1,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $74.7 million, marking a year-over-year change of. This contributed to the annual value of $74.7 million for FY2020, which is 678845.45% up from last year.
  • According to the latest figures from FY2020, AbCellera Biologics' Preferred Shares Issued is $74.7 million, which was up 678,845.45% from -$11,000 recorded in FY2019.
  • Over the past 5 years, AbCellera Biologics' Preferred Shares Issued peaked at $74.7 million during FY2020, and registered a low of -$11,000 during FY2019.
  • For the 2-year period, AbCellera Biologics' Preferred Shares Issued averaged around $37.3 million, with its median value being $37.3 million (2019).
  • Data for AbCellera Biologics' Preferred Shares Issued shows a peak YoY skyrocketed of 678,845.45% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows AbCellera Biologics' Preferred Shares Issued stood at -$11,000 in 2019, then surged by 678,845.45% to $74.7 million in 2020.